Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
| ▸ | PPARA | Q07869 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | KLKB1 | P03952 | 3/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6289406 | 0.98 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL8759348 | 0.85 | PPARA (0.61) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL3846227 | 0.84 | KLKB1 (0.71) | ALDH1A1KDM4ECYP3A4PTPN1CA12 | |
| SCHEMBL8815944 | 0.84 | KLKB1 (0.71) | ALDH1A1KDM4ECYP3A4PTPN1CA12 | |
| SCHEMBL6451619 | 0.83 | ALDH1A1 (0.52) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL8759962 | 0.82 | PPARA (0.67) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL17422566 | 0.82 | KLKB1 (0.43) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL1401513 | 0.82 | ALDH1A1 (0.57) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL2837159 | 0.82 | ALDH1A1 (0.57) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL13209792 | 0.81 | ALDH1A1 (0.53) | ALDH1A1KDM4EMAPTCYP3A4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572459-B2 | Prevention infections in humans, animals | STARPHARMA PTY LTD. (AU) | 2009-08-11 | — | — | US | claimed |
| EP-1113806-B1 | ANIONIC OR CATIONIC DENDRIMER ANTIMICROBIAL OR ANTIPARASITIC COMPOSITIONS | STARPHARMA PTY LTD (AU) | 2007-09-05 | — | — | EP | claimed |
| EP-0765357-B9 | ANTIVIRAL DENDRIMERS | STARPHARMA PTY LTD (AU) | 2006-08-16 | — | — | EP | claimed |
| EP-0927217-B1 | ANGIOGENIC INHIBITORY COMPOUNDS | STARPHARMA PTY LTD (AU) | 2006-05-03 | — | — | EP | claimed |
| EP-0765357-B8 | ANTIVIRAL DENDRIMERS | STARPHARMA PTY LTD (AU) | 2006-03-08 | — | — | EP | claimed |
| EP-0765357-B1 | ANTIVIRAL DENDRIMERS | BIOMOLECULAR RES INST LTD (AU) | 2005-12-14 | — | — | EP | claimed |
| CN-1161128-C | Angiogenic inhibitory compounds | О | 2004-08-11 | — | — | CN | claimed |
| EP-1113805-A4 | INHIBITION OF TOXIC MATERIALS OR SUBSTANCES USING DENDRIMERS | STARPHARMA LTD (AU) | 2004-05-19 | — | — | EP | claimed |
| CN-1134486-C | Antiviral dendrimers | BIOMOLECULAR RES INST LTD (AU) | 2004-01-14 | — | — | CN | claimed |
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | STARPHARMA LIMITED | 2003-07-10 | — | — | US | claimed |
| US-6190650-B1 | FOR PROPHYLAXIS AND THERAPY OF VIRAL DISEASES IN HUMANS AND ANIMALS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 2001-02-20 | — | — | US | claimed |
| WO-2000015240-A1 | ANIONIC OR CATIONIC DENDRIMER ANTIMICROBIAL OR ANTIPARASITIC COMPOSITIONS | STARPHARMA LIMITED (AU) | 2000-03-23 | — | — | WO | claimed |
| WO-2000015239-A1 | INHIBITION OF TOXIC MATERIALS OR SUBSTANCES USING DENDRIMERS | STARPHARMA LIMITED (AU) | 2000-03-23 | — | — | WO | claimed |
| CN-1225654-A | Angiogenic inhibitory compounds | BIOMOLECULAR RES INST LTD (AU) | 1999-08-11 | — | — | CN | claimed |
| EP-0927217-A1 | ANGIOGENIC INHIBITORY COMPOUNDS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1999-07-07 | — | — | EP | claimed |
| WO-1998003573-A1 | ANGIOGENIC INHIBITORY COMPOUNDS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1998-01-29 | — | — | WO | claimed |
| EP-0765357-A4 | ANTIVIRAL DENDRIMERS | BIOMOLECULAR RES INST LTD (AU) | 1997-07-30 | — | — | EP | claimed |
| CN-1154123-A | Antiviral dendrimers | BIOMOLECULAR RES INST LTD (AU) | 1997-07-09 | — | — | CN | claimed |
| EP-0765357-A1 | ANTIVIRAL DENDRIMERS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1997-04-02 | — | — | EP | claimed |
| WO-1995034595-A1 | ANTIVIRAL DENDRIMERS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1995-12-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | FUT6, B3GNT2, SIGLEC7 | ALDH1A1 2800/4885KDM4E 4773/4885MAPT 3726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.